Charles River Laboratories | CRL - Activos Circulantes





Activos Circulantes Cambio Fecha
Agilent USD 4.69B 70M 2026-06
Align Technology USD 2.73B 63.03M 2026-09
Bio-Rad Laboratories USD 3.08B 58.1M 2026-09
Bruker USD 2.16B 67.9M 2026-09
Cardinal Health USD 40.99B 2.24B 2026-09
Charles River Laboratories USD 1.54B 5.92M 2026-09
Cigna USD 47.23B 241M 2026-09
Concord Medical Services Hldg CNY 941.91M 83.42M 2025-12
CVS Health USD 79.39B 4.05B 2026-09
Danaher USD 14.79B 1.41B 2026-09
Dentsply International USD 1.98B 50M 2026-09
Elevance Health USD 68.52B 1.34B 2026-09
Humana USD 39.61B 477M 2026-09
Illumina USD 3.04B 201M 2026-09
Incyte USD 5.52B 505.2M 2026-09
Intrexon USD 23.72M 45.04M 2024-06
IQVIA Holdings USD 6.45B 225M 2026-09
Laboratory Of America USD 3.97B 151.3M 2026-09
Lakefront Biotherapeutics EUR 2.31B 751.38M 2026-06
Lonza CHF 8B 3.41B 2025-12
McKesson USD 66.68B 3.85B 2026-09
Merck EUR 15.14B 1.37B 2026-09
Mettler Toledo International USD 1.38B 28.79M 2026-09
Novartis USD 28.75B 1.4B 2026-09
Pfizer USD 45.01B 3.65B 2026-09
Quest Diagnostics USD 3.12B 273M 2026-09
Revvity USD 1.86B 436.33M 2026-09
Thermo Fisher Scientific USD 25.62B 2.25B 2026-09
United Therapeutics USD 2.88B 603.5M 2026-09
UnitedHealth USD 85.6B 1.27B 2026-09
Veradigm USD 679.65M 131.12M 2022-12
Waters USD 3.9B 186M 2026-06
West Pharmaceutical Services USD 1.82B 9M 2026-09